diosgenin has been researched along with Hyperglycemia, Postprandial in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Jayaraman, S; Kumar, PK; Pari, L; Piramanayagam, S; Prasad, M; Rajagopal, P; Veeraraghavan, VP | 1 |
Claridge, TDW; Drijfhout, FP; Etuk, IC; Li, WW; Okokon, JE; Thomas, PS | 1 |
Han, X; Jin, Y; Liu, KX; Peng, JY; Qi, Y; Xu, LN; Xu, YW; Yin, LH; Zhao, YY | 1 |
Fujita, S; Iemitsu, M; Sato, K | 1 |
Kalailingam, P; Kaliaperumal, R; Kannaian, B; Tamilmani, E | 1 |
Begum, MS; Meriga, B; Mohan, K; Naidu, PB; Ponmurugan, P; RavindarNaik, R; Saravanan, G | 1 |
6 other study(ies) available for diosgenin and Hyperglycemia, Postprandial
Article | Year |
---|---|
Diosgenin inhibits ER stress-induced inflammation in aorta via iRhom2/TACE mediated signaling in experimental diabetic rats: An in vivo and in silico approach.
Topics: ADAM17 Protein; Animals; Aorta; Cytokines; Diabetes Mellitus, Experimental; Diosgenin; Endoplasmic Reticulum Stress; Hyperglycemia; Hypertension; Inflammation; Lipids; Male; Molecular Docking Simulation; Oxidative Stress; Rats; Streptozocin; Tumor Necrosis Factor-alpha | 2022 |
In vivo antihyperglycaemic and antihyperlipidemic activities and chemical constituents of Solanum anomalum.
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diosgenin; Hyperglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Plant Extracts; Rats; Solanum | 2022 |
Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Diosgenin; Gene Expression Regulation; Gluconeogenesis; Glycolipids; Hep G2 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipogenesis; Liver; Male; Mice, Inbred C57BL; MicroRNAs; Rats, Wistar; STAT3 Transcription Factor | 2020 |
Acute administration of diosgenin or dioscorea improves hyperglycemia with increases muscular steroidogenesis in STZ-induced type 1 diabetic rats.
Topics: Animals; Blood Glucose; Dehydroepiandrosterone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dioscorea; Diosgenin; Enzyme-Linked Immunosorbent Assay; Glucose Transporter Type 4; Hyperglycemia; Immunoblotting; Isoenzymes; Male; Muscle, Skeletal; Protein Kinase C; Protein Kinase C-epsilon; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction | 2014 |
Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in streptozotocin (STZ)-induced diabetic rats.
Topics: Animals; Blood Glucose; Cardiovascular Diseases; Costus; Diabetes Mellitus, Experimental; Diosgenin; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Pancreas; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Streptozocin | 2014 |
Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Dietary Fats; Diosgenin; Dyslipidemias; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Male; Phytotherapy; Plant Extracts; Rats, Wistar; Trigonella; Weight Gain | 2015 |